Review



primary antibodies against dnmt3a  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc primary antibodies against dnmt3a
    Sequences of primers used in qPCR.
    Primary Antibodies Against Dnmt3a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/dnmt3a+antibody/pmc07317242-116-24-35
    Average 90 stars, based on 1 article reviews
    primary antibodies against dnmt3a - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes"

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes

    Journal: EBioMedicine

    doi: 10.1016/j.ebiom.2020.102835

    Sequences of primers used in qPCR.
    Figure Legend Snippet: Sequences of primers used in qPCR.

    Techniques Used: Sequencing

    Altered expression of DNMTs and TETs in CSCCs compared with adjacent normal tissues. (a) The relative expression levels of DNMTs and TETs in CSCC and adjacent normal tissues. Data are shown as means ± SD. The statistical significance was assessed by the Student's t -test. (b) The Pearson's correlation between expression level (2 −△Ct ) or methylation level of ID4 and expression levels (2 −△△Ct ) of DNMT1, DNMT3A, DNMT3B, TET1, TET2, and TET3, which were measured by MSP and qPCR in the same patient sets.
    Figure Legend Snippet: Altered expression of DNMTs and TETs in CSCCs compared with adjacent normal tissues. (a) The relative expression levels of DNMTs and TETs in CSCC and adjacent normal tissues. Data are shown as means ± SD. The statistical significance was assessed by the Student's t -test. (b) The Pearson's correlation between expression level (2 −△Ct ) or methylation level of ID4 and expression levels (2 −△△Ct ) of DNMT1, DNMT3A, DNMT3B, TET1, TET2, and TET3, which were measured by MSP and qPCR in the same patient sets.

    Techniques Used: Expressing, Methylation

    Related Articles

    Staining:

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes
    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Article Title: Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca 2+ -activated K + channel function in ovine uterine arteries
    Article Snippet: After blocking nonspecific binding sites by a Tris-buffered saline solution containing 5% dry milk, membranes were incubated with primary antibodies against the BK Ca channel beta-1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA), DNMT1 (Cell Signaling Technology, Danvers, MA), DNMT3a (Cell Signaling Technology), and DNMT3b (Novus Biologicals, Littleton, CO).

    Incubation:

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes
    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Article Title: Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca 2+ -activated K + channel function in ovine uterine arteries
    Article Snippet: After blocking nonspecific binding sites by a Tris-buffered saline solution containing 5% dry milk, membranes were incubated with primary antibodies against the BK Ca channel beta-1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA), DNMT1 (Cell Signaling Technology, Danvers, MA), DNMT3a (Cell Signaling Technology), and DNMT3b (Novus Biologicals, Littleton, CO).

    Sequencing:

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes
    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Article Title: Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca 2+ -activated K + channel function in ovine uterine arteries
    Article Snippet: After blocking nonspecific binding sites by a Tris-buffered saline solution containing 5% dry milk, membranes were incubated with primary antibodies against the BK Ca channel beta-1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA), DNMT1 (Cell Signaling Technology, Danvers, MA), DNMT3a (Cell Signaling Technology), and DNMT3b (Novus Biologicals, Littleton, CO).

    Expressing:

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes
    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Article Title: Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca 2+ -activated K + channel function in ovine uterine arteries
    Article Snippet: After blocking nonspecific binding sites by a Tris-buffered saline solution containing 5% dry milk, membranes were incubated with primary antibodies against the BK Ca channel beta-1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA), DNMT1 (Cell Signaling Technology, Danvers, MA), DNMT3a (Cell Signaling Technology), and DNMT3b (Novus Biologicals, Littleton, CO).

    Methylation:

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes
    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Article Title: Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca 2+ -activated K + channel function in ovine uterine arteries
    Article Snippet: After blocking nonspecific binding sites by a Tris-buffered saline solution containing 5% dry milk, membranes were incubated with primary antibodies against the BK Ca channel beta-1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA), DNMT1 (Cell Signaling Technology, Danvers, MA), DNMT3a (Cell Signaling Technology), and DNMT3b (Novus Biologicals, Littleton, CO).

    Blocking Assay:

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes
    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Article Title: Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca 2+ -activated K + channel function in ovine uterine arteries
    Article Snippet: After blocking nonspecific binding sites by a Tris-buffered saline solution containing 5% dry milk, membranes were incubated with primary antibodies against the BK Ca channel beta-1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA), DNMT1 (Cell Signaling Technology, Danvers, MA), DNMT3a (Cell Signaling Technology), and DNMT3b (Novus Biologicals, Littleton, CO).

    Binding Assay:

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes
    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Article Title: Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca 2+ -activated K + channel function in ovine uterine arteries
    Article Snippet: After blocking nonspecific binding sites by a Tris-buffered saline solution containing 5% dry milk, membranes were incubated with primary antibodies against the BK Ca channel beta-1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA), DNMT1 (Cell Signaling Technology, Danvers, MA), DNMT3a (Cell Signaling Technology), and DNMT3b (Novus Biologicals, Littleton, CO).

    Saline:

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes
    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Article Title: Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca 2+ -activated K + channel function in ovine uterine arteries
    Article Snippet: After blocking nonspecific binding sites by a Tris-buffered saline solution containing 5% dry milk, membranes were incubated with primary antibodies against the BK Ca channel beta-1 subunit (Santa Cruz Biotechnology, Santa Cruz, CA), DNMT1 (Cell Signaling Technology, Danvers, MA), DNMT3a (Cell Signaling Technology), and DNMT3b (Novus Biologicals, Littleton, CO).



    Similar Products

    primary antibodies against dnmt3a, dnmt3b, pdgfa, col1a1 and α-sma  (GeneTex)
    90
    GeneTex primary antibodies against dnmt3a, dnmt3b, pdgfa, col1a1 and α-sma
    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, <t>and</t> <t>α-SMA</t> in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 <t>and</t> <t>α-SMA</t> in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 <t>and</t> <t>α-SMA</t> decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group
    Primary Antibodies Against Dnmt3a, Dnmt3b, Pdgfa, Col1a1 And α Sma, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/col1a1+antibody/pmc12265160-71-19-20
    Average 90 stars, based on 1 article reviews
    primary antibodies against dnmt3a, dnmt3b, pdgfa, col1a1 and α-sma - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    primary antibodies against dnmt3a  (Santa Cruz Biotechnology)
    94
    Santa Cruz Biotechnology primary antibodies against dnmt3a
    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, <t>and</t> <t>α-SMA</t> in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 <t>and</t> <t>α-SMA</t> in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 <t>and</t> <t>α-SMA</t> decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group
    Primary Antibodies Against Dnmt3a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/Dnmt3a+Antibody/pm40570973-56-0-9
    Average 94 stars, based on 1 article reviews
    primary antibodies against dnmt3a - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    primary antibodies against dnmt1, dnmt3a, dnmt3b, pdgfa, col1a1 and α-sma  (GeneTex)
    90
    GeneTex primary antibodies against dnmt1, dnmt3a, dnmt3b, pdgfa, col1a1 and α-sma
    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, <t>and</t> <t>α-SMA</t> in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 <t>and</t> <t>α-SMA</t> in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 <t>and</t> <t>α-SMA</t> decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group
    Primary Antibodies Against Dnmt1, Dnmt3a, Dnmt3b, Pdgfa, Col1a1 And α Sma, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/dnmt1+antibody/ppr0929729-71-20-21
    Average 90 stars, based on 1 article reviews
    primary antibodies against dnmt1, dnmt3a, dnmt3b, pdgfa, col1a1 and α-sma - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    primary antibodies against dnmt3a  (Active Motif)
    90
    Active Motif primary antibodies against dnmt3a
    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, <t>and</t> <t>α-SMA</t> in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 <t>and</t> <t>α-SMA</t> in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 <t>and</t> <t>α-SMA</t> decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group
    Primary Antibodies Against Dnmt3a, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/anti+dnmt3a/10__1016_slash_j__cej__2024__154568-213-0-9
    Average 90 stars, based on 1 article reviews
    primary antibodies against dnmt3a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    primary antibodies against dnmt3a, dnmt3b, cleaved caspase-3, bax, p21, ki67 and pcna  (GeneTex)
    90
    GeneTex primary antibodies against dnmt3a, dnmt3b, cleaved caspase-3, bax, p21, ki67 and pcna
    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, <t>and</t> <t>α-SMA</t> in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 <t>and</t> <t>α-SMA</t> in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 <t>and</t> <t>α-SMA</t> decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group
    Primary Antibodies Against Dnmt3a, Dnmt3b, Cleaved Caspase 3, Bax, P21, Ki67 And Pcna, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/col1a1+antibody/ppr0849719-62-22-23
    Average 90 stars, based on 1 article reviews
    primary antibodies against dnmt3a, dnmt3b, cleaved caspase-3, bax, p21, ki67 and pcna - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    primary antibodies against dnmt3a a19659  (ABclonal Biotechnology)
    90
    ABclonal Biotechnology primary antibodies against dnmt3a a19659
    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, <t>and</t> <t>α-SMA</t> in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 <t>and</t> <t>α-SMA</t> in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 <t>and</t> <t>α-SMA</t> decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group
    Primary Antibodies Against Dnmt3a A19659, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/anti+dnmt3a+a19659/pm38309617-53-18-48
    Average 90 stars, based on 1 article reviews
    primary antibodies against dnmt3a a19659 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    primary antibodies against dnmt3a, dnmt3b, ha, hcv e2, gtubulin, p53  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology primary antibodies against dnmt3a, dnmt3b, ha, hcv e2, gtubulin, p53
    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, <t>and</t> <t>α-SMA</t> in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 <t>and</t> <t>α-SMA</t> in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 <t>and</t> <t>α-SMA</t> decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group
    Primary Antibodies Against Dnmt3a, Dnmt3b, Ha, Hcv E2, Gtubulin, P53, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/anti+dnmt3a/pm35066375-49-16-18
    Average 90 stars, based on 1 article reviews
    primary antibodies against dnmt3a, dnmt3b, ha, hcv e2, gtubulin, p53 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    primary polyclonal antibody against dnmt3a  (Novus Biologicals)
    90
    Novus Biologicals primary polyclonal antibody against dnmt3a
    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, <t>and</t> <t>α-SMA</t> in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 <t>and</t> <t>α-SMA</t> in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 <t>and</t> <t>α-SMA</t> decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group
    Primary Polyclonal Antibody Against Dnmt3a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/anti+dnmt3a/10__1096_slash_fj__202000253rr-86-6-12
    Average 90 stars, based on 1 article reviews
    primary polyclonal antibody against dnmt3a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    primary antibodies against dnmt3a  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc primary antibodies against dnmt3a
    Sequences of primers used in qPCR.
    Primary Antibodies Against Dnmt3a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/dnmt3a+antibody/pmc07317242-116-24-35
    Average 90 stars, based on 1 article reviews
    primary antibodies against dnmt3a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    labeled primary antibodies against dnmt3a  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc labeled primary antibodies against dnmt3a
    Effect of alpinetin on protein expression <t>of</t> <t>DNMT3A.</t> Expressions of <t>PPAR</t> and DNMT3A in RAW246.7 cells were determined by Western blot assay after cells were treated with alpinetin (0, 50, 100, 200, 500, 1,000 g/ml). Data were expressed as means ± SD . # p < .05 versus control group, ▼ p < .05 versus 1 mg/ml Alp group
    Labeled Primary Antibodies Against Dnmt3a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+dnmt3a/dnmt3a+antibody/pmc06978396-78-8-17
    Average 90 stars, based on 1 article reviews
    labeled primary antibodies against dnmt3a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, and α-SMA in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 and α-SMA in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 and α-SMA decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group

    Journal: European Journal of Medical Research

    Article Title: MiRNA-29b accelerates the PDGF in exosomes and stimulates hepatic stellate cells to promote liver fibrosis in biliary atresia

    doi: 10.1186/s40001-025-02731-z

    Figure Lengend Snippet: Effects of miRNA-29b overexpression and inhibition in exosomes on the expression of DNMT3a, DNMT3b, PDGFA, COL1A1, and α-SMA in LX-2 cells and verification of miRNA-29b target genes by dual luciferase assays. a miRNA-29b-overexpressing exosomes were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Up group were significantly decreased. b The transcription level of PDGFA in the b Up group was significantly increased. c The expression levels of COL1A1 and α-SMA in the Up group were increased. d Exosomes with low miRNA-29b expression were cocultured with LX-2 cells, and the expression levels of DNMT3a and DNMT3b in the Down group were significantly increased. e The expression level of PDGFA in the Down group was decreased. f The expression of COL1A1 and α-SMA decreased in the Down group. g Double luciferase experiments proved that DNMT3a and DNMT3b were the target genes of miR-29b-3p. Note: Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; a–f : LX-2 cells cocultured with exosomes from 3 independent experiments (n = 3); g: Data from 4 biological replicates (n = 4). * indicates p < 0.05 compared with the control group

    Article Snippet: The membrane was blocked with 5% skim milk and incubated with primary antibodies against DNMT3a, DNMT3b, PDGFA, COL1A1 and α-SMA (GeneTex, Abcam).

    Techniques: Over Expression, Inhibition, Expressing, Luciferase, Control

    Effect of 5-AZAC on LX-2 cells cocultured with miRNA-29b overexpression and inhibition exosomes. a The miRNA-29b overexpression exosome + 5Azac group showed decreased expression of DNMT3a and DNMT3b; b the miRNA-29b overexpression exosome + 5Azac group showed increased expression of PDGFA; c The expression of COL1A1 and α-SMA in the miRNA-29b overexpressed exosome + 5Azac group increased; d The expression levels of DNMT3a and DNMT3b in the miRNA-29b low-expression exosome + 5Azac group were decreased; e the miRNA-29b low expression exosome + 5Azac group showed increased expression of PDGFA; f The expression of COL1A1 and α-SMA increased in the miRNA-29b low-expression exosome + 5Azac group. Note : Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Up + 5Azac: miRNA-29b-overexpressing exosomes + 5Azac were cocultured with LX-2 cells. Down + 5Azac: Exosomes with low expression of miRNA-29b + 5Azac were cocultured with LX-2 cells; a – f : Data from 3 independent experiments (n = 3). * indicates p < 0.05 compared with the control group

    Journal: European Journal of Medical Research

    Article Title: MiRNA-29b accelerates the PDGF in exosomes and stimulates hepatic stellate cells to promote liver fibrosis in biliary atresia

    doi: 10.1186/s40001-025-02731-z

    Figure Lengend Snippet: Effect of 5-AZAC on LX-2 cells cocultured with miRNA-29b overexpression and inhibition exosomes. a The miRNA-29b overexpression exosome + 5Azac group showed decreased expression of DNMT3a and DNMT3b; b the miRNA-29b overexpression exosome + 5Azac group showed increased expression of PDGFA; c The expression of COL1A1 and α-SMA in the miRNA-29b overexpressed exosome + 5Azac group increased; d The expression levels of DNMT3a and DNMT3b in the miRNA-29b low-expression exosome + 5Azac group were decreased; e the miRNA-29b low expression exosome + 5Azac group showed increased expression of PDGFA; f The expression of COL1A1 and α-SMA increased in the miRNA-29b low-expression exosome + 5Azac group. Note : Normal: untreated LX-2 cells in the blank control group; control: negative empty exosomes were cocultured with LX-2 cells. Up + 5Azac: miRNA-29b-overexpressing exosomes + 5Azac were cocultured with LX-2 cells. Down + 5Azac: Exosomes with low expression of miRNA-29b + 5Azac were cocultured with LX-2 cells; a – f : Data from 3 independent experiments (n = 3). * indicates p < 0.05 compared with the control group

    Article Snippet: The membrane was blocked with 5% skim milk and incubated with primary antibodies against DNMT3a, DNMT3b, PDGFA, COL1A1 and α-SMA (GeneTex, Abcam).

    Techniques: Over Expression, Inhibition, Expressing, Control

    Detection of the relative expression of transcript level and protein level of each gene in UP group and Up + 5Azac group, Down group and Down + 5Azac group. a–b: At both transcriptional and protein levels, the Up + 5Azac group showed significantly lower DNMT3a/3b enzyme activities, higher PDGFA methylation levels, and increased COL1A1 and α-SMA expression compared to the Up group. c-d: At the transcriptional and protein levels, the Down + 5Azac group showed decreased DNMT3a/3b enzyme activity, increased PDGFA methylation levels, and increased COL1A1 and α-SMA expression compared to the Down group. Note: Up: exosomes overexpressing miRNA-29b were cocultured with LX-2 cells; Up + 5Azac: miRNA-29b -overexpressing exosomes + 5Azac were cocultured with LX-2 cells; Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; Down + 5Azac: Exosomes with low expression of miRNA-29b + 5Azac were cocultured with LX-2 cells. a – d : LX-2 cells cocultured with exosomes from 6 independent experiments (n = 6). * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001; **** indicates p < 0.0001

    Journal: European Journal of Medical Research

    Article Title: MiRNA-29b accelerates the PDGF in exosomes and stimulates hepatic stellate cells to promote liver fibrosis in biliary atresia

    doi: 10.1186/s40001-025-02731-z

    Figure Lengend Snippet: Detection of the relative expression of transcript level and protein level of each gene in UP group and Up + 5Azac group, Down group and Down + 5Azac group. a–b: At both transcriptional and protein levels, the Up + 5Azac group showed significantly lower DNMT3a/3b enzyme activities, higher PDGFA methylation levels, and increased COL1A1 and α-SMA expression compared to the Up group. c-d: At the transcriptional and protein levels, the Down + 5Azac group showed decreased DNMT3a/3b enzyme activity, increased PDGFA methylation levels, and increased COL1A1 and α-SMA expression compared to the Down group. Note: Up: exosomes overexpressing miRNA-29b were cocultured with LX-2 cells; Up + 5Azac: miRNA-29b -overexpressing exosomes + 5Azac were cocultured with LX-2 cells; Down: exosomes with low miRNA-29b expression were cocultured with LX-2 cells; Down + 5Azac: Exosomes with low expression of miRNA-29b + 5Azac were cocultured with LX-2 cells. a – d : LX-2 cells cocultured with exosomes from 6 independent experiments (n = 6). * indicates p < 0.05; ** indicates p < 0.01; *** indicates p < 0.001; **** indicates p < 0.0001

    Article Snippet: The membrane was blocked with 5% skim milk and incubated with primary antibodies against DNMT3a, DNMT3b, PDGFA, COL1A1 and α-SMA (GeneTex, Abcam).

    Techniques: Expressing, Methylation, Activity Assay

    Sequences of primers used in qPCR.

    Journal: EBioMedicine

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes

    doi: 10.1016/j.ebiom.2020.102835

    Figure Lengend Snippet: Sequences of primers used in qPCR.

    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Techniques: Sequencing

    Altered expression of DNMTs and TETs in CSCCs compared with adjacent normal tissues. (a) The relative expression levels of DNMTs and TETs in CSCC and adjacent normal tissues. Data are shown as means ± SD. The statistical significance was assessed by the Student's t -test. (b) The Pearson's correlation between expression level (2 −△Ct ) or methylation level of ID4 and expression levels (2 −△△Ct ) of DNMT1, DNMT3A, DNMT3B, TET1, TET2, and TET3, which were measured by MSP and qPCR in the same patient sets.

    Journal: EBioMedicine

    Article Title: UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes

    doi: 10.1016/j.ebiom.2020.102835

    Figure Lengend Snippet: Altered expression of DNMTs and TETs in CSCCs compared with adjacent normal tissues. (a) The relative expression levels of DNMTs and TETs in CSCC and adjacent normal tissues. Data are shown as means ± SD. The statistical significance was assessed by the Student's t -test. (b) The Pearson's correlation between expression level (2 −△Ct ) or methylation level of ID4 and expression levels (2 −△△Ct ) of DNMT1, DNMT3A, DNMT3B, TET1, TET2, and TET3, which were measured by MSP and qPCR in the same patient sets.

    Article Snippet: The slides were first blocked with normal goat serum at room temperature for 30 min to minimize nonspecific staining, then incubated overnight with primary antibodies against DNMT1 (1:100, Absin Bioscience Inc., Shanghai, China), DNMT3A (1:50, CST, USA), DNMT3B (1:50, Abcam, UK), TET1 (1:100, Absin Bioscience Inc., Shanghai, China), TET2 (1:100, Absin Bioscience Inc., Shanghai, China), and TET3 (1:100, Abcam, UK).

    Techniques: Expressing, Methylation

    Effect of alpinetin on protein expression of DNMT3A. Expressions of PPAR and DNMT3A in RAW246.7 cells were determined by Western blot assay after cells were treated with alpinetin (0, 50, 100, 200, 500, 1,000 g/ml). Data were expressed as means ± SD . # p < .05 versus control group, ▼ p < .05 versus 1 mg/ml Alp group

    Journal: Molecular Genetics & Genomic Medicine

    Article Title: Inhibitory effect of alpinetin on IL‐6 expression by promoting cytosine methylation in CpG islands in the IL‐6 promoter region

    doi: 10.1002/mgg3.993

    Figure Lengend Snippet: Effect of alpinetin on protein expression of DNMT3A. Expressions of PPAR and DNMT3A in RAW246.7 cells were determined by Western blot assay after cells were treated with alpinetin (0, 50, 100, 200, 500, 1,000 g/ml). Data were expressed as means ± SD . # p < .05 versus control group, ▼ p < .05 versus 1 mg/ml Alp group

    Article Snippet: Next, the membranes were incubated with labeled primary antibodies against PPAR and DNMT3A (all dilution at 1:1,000, Cell Signaling Technology, Danvers, MA, USA) at room temperature for 2 hr.

    Techniques: Expressing, Western Blot